Company: CSTL
Filing Date: 2025-04-09
Form Type: DEF 14A
Source: 0001447362-25-000054
Chunk: 77

Company: CASTLE BIOSCIENCES INC
Filing Date: 2025-04-09
Form: DEF 14A
Chunk 77
---
10/2021          |     |                           |  31,912 |     |                     | 10,638 |                                                                     |     | 40.52 |                                                                       |                       |      | 12/09/2031 |                        |   6,170 |            |                                                                |   164,431 |     |                                                               |       — |     |                                                                                                     |         — |     |                                                                                                                     |   |
| 12/9/2022           |     |                           |       — |     |                     |      — |                                                                     |     |     — |                                                                       |                       |    — |            |                        |  31,922 |            |                                                                |   850,721 |     |                                                               |       — |     |                                                                                                     |         — |     |                                                                                                                     |   |
| 12/23/2022          |     |                           |       — |     |                     |      — |                                                                     |     |     — |                                                                       |                       |    — |            |                        |  10,640 |            |                                                                |   283,556 |     |                                                               |       — |     |                                                                                                     |         — |     |                                                                                                                     |   |
| 3/4/2024            |     |                           |       — |     |                     |      — |                                                                     |     |     — |                                                                       |                       |    — |            |                        |  55,243 |            |                                                                | 1,472,226 |     |                                                               |  18,414 |     |                                                                                                     |   490,733 |     |                                                                                                                     |   |

(1) All of the option awards were granted under either the 2008 Plan, the 2018 Plan or the 2019 Plan and all of the stock awards were granted under the 2019 Plan. Additional information on our equity plans is set forth in Note 15 to our consolidated financial statements appearing in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024.

#### 70Castle Biosciences 2025 Proxy Statement

#### Executive Compensation Tables
(2) Except for the options to purchase 65,627 shares of common stock granted to Mr. Maetzold with a vesting commencement date of March 13, 2019, which were fully vested upon issuance, each option award vests as follows: 25% of the shares subject to the option vest on the first anniversary of the vesting commencement date